Long/short equity, biotech, healthcare, small-cap

USANA Health Sciences: This Dip Is Offering A Sweet Buying Opportunity

Despite the downward stock-price movements in the last few days, due to strategic changes in business operations, USANA (USNA) remains poised for future growth based on its consistent free cash flow, pristine balance sheet, and robust international growth opportunities. USANA will benefit largely with the expansion into mainland China and the Asia-Pacific region. In the long-term, mainland China will become a significant growth driver for USANA. In the third quarter, China represented 17% of revenue for third-quarter of 2013. USNA will continue to have an enormous cash stockpile, which currently stands at $115 million.

Further, USANA will post strong growth due to the company's expansion into new markets such as Colombia and Mexico. The worldwide policy changes and...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details